Table of Contents
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Coronary Artery Bypass Graft Market, by Type
5.1 Introduction
5.1.1 Off-Pump
5.1.2 On-Pump
5.1.3 Minimally Invasive Direct CABG
5.1.4 Endoscopic Vein Harvesting
5.1.5 Others
6 Global Coronary Artery Bypass Graft Market, by Procedure
6.1 Introduction
6.1.1 Single CABG Surgery
6.1.2 Double CABG Surgery
6.1.3 Triple CABG Surgery
6.1.4 Quadruple CABG Surgery
6.1.5 Others
7 Global Coronary Artery Bypass Graft Market, by End User
7.1 Introduction
7.1.1 Hospitals
7.1.3 Cardiology Clinics
7.1.4 Research Institutes
7.1.5 Others
8 Global Coronary Artery Bypass Graft Market, by Regions
8.1 Introduction
8.1.1 Americas
8.1.1.1 North America
8.1.1.2 South America
8.1.2 Europe
8.1.2.1 Germany
8.1.2.2 France
8.1.2.3 UK
8.1.2.4 Italy
8.1.2.5 Spain
8.1.2.6 Rest of Europe
8.1.3 Asia Pacific
8.1.3.1 Japan
8.1.3.2 China
8.1.3.3 India
8.1.3.4 Republic of Korea
8.1.3.5 Rest of Asia Pacific
8.1.4 Middle East & Africa
9 Company Landscape
9.1 Introduction
9.1.1 Mergers Acquisitions
9.1.2 Collaborations
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Dextera Surgical Inc.
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Edwards Lifesciences Corporation
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Genesee BioMedical
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Hancock Jaffe Laboratories, Inc.
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financials
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 MAQUET Holding B.V. & Co. KG.
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financials
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Neograft Inc.
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financials
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 NOVADAQ Technologies Inc.
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Sorin Group
10.8.1 Overview
10.8.2 Product/Business Segment Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Terumo Cardiovascular Systems Corporation
10.9.1 Overview
10.9.2 Product/Business Segment Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 VasoPrep Surgical
10.10.1 Overview
10.10.2 Product/Business Segment Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Scion Medical Technologies, LLC.
10.11.1 Others
11 Appendix
List of Tables
TABLE 1 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, 2023-2030 (USD MILLION)
TABLE 2 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 3 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY REGION, 2023-2030(USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY TYPE
FIGURE 4 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY PROCEDURE
FIGURE 5 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY END USER
FIGURE 6 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY REGION
FIGURE 7 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
